Ad-Tech Fee Audits and Conservative Guidance Drag TTD and SOLV Shares Lower

The equity markets witnessed a sharp divergence in performance for two prominent mid-to-large cap entities on March 24, 2026, as The Trade Desk (TTD) and Solventum (SOLV) both saw their shares slide amid mounting sector-specific pressures. While the broader indices remained relatively stable, the volatility in these two names highlights the increasing scrutiny on transparency in the digital advertising ecosystem and the execution risks inherent in large-scale industrial spin-offs. For investors, the simultaneous decline of an ad-tech leader and a healthcare giant underscores a market environment that is increasingly unforgiving of regulatory uncertainty and sluggish growth projections.

The Trade Desk's decline is directly linked to an escalating conflict with the world's largest advertising agencies. On March 24, Omnicom Group officially launched a comprehensive audit of The Trade Desk’s fee structure, a move that sent shockwaves through the programmatic advertising sector. This development follows weeks of public sparring between TTD and Publicis Groupe, with the latter reportedly warning its clients against using the platform due to concerns over hidden margins and a perceived lack of transparency. For a company like The Trade Desk, which has long positioned itself as the 'transparent' alternative to the 'walled gardens' of Google and Meta, these allegations strike at the core of its value proposition. The Omnicom audit represents a formalization of these concerns, suggesting that the era of unquestioned trust between independent demand-side platforms (DSPs) and major holding companies may be ending.

“

The primary catalyst for the current slide appears to be a lack of investor confidence in the company’s 2026 organic sales growth guidance, which was recently pegged at a modest 2% to 3%.

Industry analysts suggest that the TTD-Publicis-Omnicom rift is less about technical capabilities and more about a fundamental struggle over who captures the margin in the programmatic supply chain. As agencies face their own margin pressures, they are increasingly looking to squeeze costs from technology partners. If the Omnicom audit reveals discrepancies or if other major agencies follow suit, The Trade Desk could face a significant contraction in its take rate, which has historically been one of the most resilient in the industry. The short-term market reaction reflects fears that TTD’s growth could be hampered by a protracted 'war against transparency' that alienates its primary customer base: the global ad agencies.

Simultaneously, Solventum, the healthcare-focused spin-off from 3M, saw its shares continue a downward trajectory that began earlier in the quarter. The primary catalyst for the current slide appears to be a lack of investor confidence in the company’s 2026 organic sales growth guidance, which was recently pegged at a modest 2% to 3%. While management has emphasized a strategy of 'portfolio optimization' and margin expansion, the market remains skeptical of the company’s ability to accelerate growth in a competitive MedSurg and Dental Solutions landscape. As a newly independent entity, Solventum is still in the process of proving its operational efficiency away from the 3M umbrella, and the current sell-off suggests that the 'wait-and-see' approach from institutional investors is turning into active divestment.